Source Post
The creator discusses Optimi Health Corp as a potential beneficiary of the recent U.S. executive order fast...
Sep 14, 2026
The creator discusses Optimi Health Corp as a potential beneficiary of the recent U.S. executive order fast-tracking psychedelic medicine research. While highlighting the company's regulatory positioning, the creator emphasizes that this is a speculative policy play rather than a fundamental business investment due to poor financial performance and lack of FDA-approved products.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.